Regulated expression of diphtheria toxin in prostate cancer cells

Molecular Therapy

Volumn 6, Issue 4, 2002, Pages 537-545

  Peng, Weidan ^a   Verbitsky, Amy ^a   Bao, Yunhua ^a   Sawicki, Janet A ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Adenoviral vector; Androgen ablation; Androgen independent; Cancer; diphtheria toxin; Flp recombinase; Prostate; Recurrent tumors

Indexed keywords

4 HYDROXYTAMOXIFEN; ADENOVIRUS VECTOR; ANDROGEN; BETA GALACTOSIDASE; DIPHTHERIA TOXIN; PROTEIN BCL 2; RECOMBINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL KILLING; CONTROLLED STUDY; DNA RECOMBINATION; GENE CONTROL; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; RECURRENT CANCER; TARGET CELL; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0036798893     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0694     Document Type: Article

References (39)

1. Pound, C. R., et al. (1999). Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597.
2. Lidor, Y. J., et al. (1997). In vitro expression of the diphtheria toxin A-chain under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines. Am. J. Obstet. Gynecol. 177: 79-585.
3. Maxwell, I. H., Glode, L. M., and Maxwell, F. (1991). Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells. Cancer Res. 51: 4299-4304.
4. Maxwell, I. H., Maxwell, F., and Globe, L. M. (1986). Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: Possible strategy for inducing cancer cell suicide. Cancer Res. 46: 4660-4664.
5. Murayama, Y., et al. (1999). Cell-specific expression of the diphtheria toxin A-chain coding sequence under the control of the upstream region of the human α-fetoprotein gene. J. Surg. Oncol. 70: 145-149.
6. Brocard, J., Feil, R., Chambon, P., and Metzger, D. (1998). A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor. Nucleic Acids Res. 26: 4086-4090.
7. Brocard, J., et al. (1997). Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc. Natl. Acad. Sci. USA 94: 14559-14563.
8. Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K., and McMahon, A. P. (1998). Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8: 1323-1326.
9. Vasioukhin, V., Degenstein, L., Wise, B., and Fuchs, E. (1999). The magical touch: Genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc. Natl. Acad. Sci. USA 96: 8551-8556.
10. Angrand, P.-O., Woodroofe, C. P., Buchholz, F., and Stewart, A. F. (1998). Inducible expression based on regulated recombination: a single vector strategy for stable expression in cultured cells. Nucleic Acids Res. 26: 3263-3269.
11. Lee, E. J., and Jameson, J. L. (2002). Cell-specific Cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: Potential for cytotoxic gene therapy. Hum. Gene Ther. 13: 533-542.
12. Colombel, M., et al. (1993). Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 143: 390-400.
13. Liu, A. Y., Corey, E., Bladou, F., Lange, P. H., and Vessella, R. L. (1996). Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration. Int. J. Cancer. 65: 85-89.
14. McDonnell, T. J., et al. (1992). Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52: 6940-6944.
15. Perlman, H., Zhang, X., Chen, M.-W., Walsh, K., and Buttyan, R. (1999). An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ. 6: 48-54.
16. Raffo, A. J., et al. (1995). Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55: 4438-4445.
17. Dymecki, S. (1996). Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93: 6191-6196.
18. Dymecki, S., and Tomasiewicz, H. (1998). Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse. Dev. Biol. 201; 57-65.
19. Fiering, S., et al. (1995). Targeted deletion of 5′HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev. 9: 2203-2213.
20. Jung, S., Rajewsky, K., and Radbruch, A. (1993). Shutdown of class switch recombination by deletion of a switch region control element. Science 259: 984-987.
21. Logie, C., and Stewart, A. F. (1995). Ligand-regulated site-specific recombination. Proc. Natl. Acad. Sci. USA 92: 5940-5944.
22. Ludwig, D. L., and Stringer, J. R. (1994). Spontaneous and induced homologous recombination between lacZ chromosomal direct repeats in CV-1 cells. Somat. Cell Mol. Genet. 20: 11-25.
23. O'Gorman, S., Fox, D. T., and Wahl, G. M. (1991). Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251: 1351-1355.
24. Sawicki, J. A., Monks, B., and Morris, R. J. (1998). Cell-specific ecdysone-inducible expression of FLP recombinase in mammalian cells. BioTechniques 25: 868-875.
25. Feil, R., et al. (1996). Ligand-activated site-specific recombination in mice. Proc. Natl. Acad Sci. USA 93: 10887-10890.
26. van der Poel, H. G., et al. (2001). A novel method for the determination of a basal gene expression of tissue-specific promoters: An analysis of prostate-specific promoters. Cancer Gene Ther. 8: 927-935.
27. Yamaizumi, M., Mekada, E., Uchida, T., and Okada, Y. (1978). One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 15: 245-250.
28. Li, Y., et al. (2002). Prostate-specific expression of the diphtheria toxin A chain (DT-A): Studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer. Cancer Res. 62: 2576-2582.
29. Morsy, M. A., and Caskey, T. (1999). Expanded-capacity adenoviral vectors-the helper-dependent vectors. MoL. Med. Today. 5: 18-24.
30. Thomas, C. E., Schiedner, G., Kochanik, S., Castro, M. G., and Lowenstein, P. R. (2001). Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors. Hum. Gene Ther. 12: 839-846.
31. Sato, Y., et al. (1998). Enjanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochem. Biophys. Res. Commun. 244: 455-462.
32. Kijima, T., et al. (1999). Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Cancer Res. 59: 4906-4911.
33. Thomson, J. M., and Parrott, W. A. (1998). pMECA: A cloning plasmid with 44 unique restriction sites that allows selection of recombinants based on colony size. BioTechniques 24: 922-928.
34. Allen, N. D., et al. (1988). Transgenes as probes for active chromosomal domains in mouse development. Nature 333: 852-855.
35. Westlake, W. J. (1971). One-sided version of the Tukey-Duckworth test. Technometrica 13: 901.
36. Miyashita, T. M., Harigai, M., Hanada, M., and Reed, J. C. (1994). Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54: 3131-3135.
37. Young, R. L., and Korsmeyer, S. J. (1993). A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol. Cell. Biol. 13: 3686-3697.
38. Harigai, M., Miyashita, T., Hanada, M., and Reed, J. C. (1996). A cis-acting element in the BCL-2 gene controls expression through translational mechanisms. Oncogene 12:1369-1374.
39. Seto, M., et al. (1988). Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 7: 123-131.